Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design
On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…
Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference
The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…
Impact of Multiple Sclerosis Symptoms (IMSS) Survey Now Live!
We are pleased to announce that the Impact of Multiple Sclerosis Symptoms (IMSS) survey is now officially live! Why is…
EMSP joins new EU funded project called More-EUROPA
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real-world data (RWD)…
MS Hive – a new opportunity for young creatives
EMSP is delighted to announce the launch of the MS Hive, an initiative for young creatives to develop their own…
Paediatric MS: Our Recommendations for Caregivers
Multiple Sclerosis was once considered a disease occurring exclusively in adulthood, however, there is growing recognition that MS can be…
